Targeted charge-reversal nanoparticles for nuclear drug delivery
Targeted charge-reversal nanoparticles for nuclear drug delivery
复制标题
DOI:
10.1002/anie.200605254
复制
发表时间:
2007-01-01
影响因子:
16.6
通讯作者:
Shen, Youqing
中科院分区:
文献类型:
--
作者:
Xu, Peisheng;Van Kirk, Edward A.;Shen, Youqing
Most cancer chemotherapy drugs, such as anthracyclines and cisplatin, target nuclear DNA to cause DNA damage and/or topoisomerase inhibition to induce cell death (apoptosis).[1, 2] In addition to the overexpressed multidrug-resistance mechanism in the cell membrane,[3, 4] drug-resistant cancer cells have many intracellular drug-resistance mechanisms to limit the access of cytosolic drugs to the nucleus.[5, 6] Consequently, only a small percentage of drugs delivered into the cytosol finally reach the nucleus. For example, less than 1% of the cisplatin molecules that enter the cell actually bind the nuclear DNA.[2] Thus, a drug carrier capable of localizing and directly releasing drugs into the nucleus would circumvent the multidrug-resistance and intracellular drug-resistance mechanisms to effectively deliver drugs to the vicinity of DNA, leading to a high therapeutic efficacy. Polymer nanoparticles [7, 8] can carry drugs preferentially to cancerous tissues by means of the enhanced permeation and retention (EPR) effect [9, 10] and bypass the multidrug resistance in the cell membrane,[11] but the nanoparticles developed to date were found retained in cytoplasmic organelles including lysosomes rather than the nucleus.[12] Nuclear localization peptides (NLPs)—short highly positively charged peptides that actively transport large proteins across the nuclear membrane—have been used to localize drug molecules from the cytosol to the nucleus.[13, 14] A cationic polymer, polyethyleneimine (PEI), has been used extensively in nonviral gene delivery. It can carry DNA across the cell membrane, harness the molecular motors to actively move along the microtubule network, and finally enter the nucleus.[15–17] NLPs and PEI, however, are highly positively charged at physiological pH. Positively charged polymers or colloidal particles can cause severe serum inhibition and are rapidly cleared from the plasma compartment,[18, 19] and thus cannot be used in vivo.An ideal regime would be to activate the cationic charges only in cancerous tissues or their intracellular compartments. Herein, we report nanoparticles with a negative-to-positive charge-reversal PEI outer layer triggered by the solid tumor extracellular acidity (pH< 7,[10, 20]) or lysosomal (pH 4–5,[21]) for nuclear drug delivery. Negatively charged polymers have little interaction with the blood components and have been used extensively in vivo.[22, 23] Amides with neighboring carboxylic acid groups exhibit pH-dependent hydrolysis.[24] The hydrolysis of model amides of primary and secondary amines made from cis-1, 2-cyclohexanedicarboxylic anhydride was tested at different pH values (Figure S1 in the Supporting Information). The amide of the secondary amine almost instantly hydrolyzed at pH 5, slightly slower at pH 6, but only 50% even after 60 h at pH 7.4. The amide of the primary amine hydrolyzed more slowly at pH 5 and 6 than that of the secondary amine amide, and did not hydrolyze at pH 7.4. Thus, we used this type of amides to preserve the primary and secondary amines of PEI: At neutral pH, the amides are stable and negatively charged because of the β-carboxylic acid groups, while at a low pH, the amides hydrolyze to regenerate the amine groups to carry cationic charges.